Harr Steve 4
4 · Sana Biotechnology, Inc. · Filed Mar 8, 2022
Insider Transaction Report
Form 4
Harr Steve
DirectorPresident & CEO
Transactions
- Award
Stock Options (Right to Buy)
2022-03-03+760,000→ 760,000 totalExercise: $5.70Exp: 2032-03-02→ Common Stock (760,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable as to 25% of the underlying shares on March 3, 2023 and in 36 equal monthly installments thereafter.